MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease

Mucosal Immunology

Volumn 2, Issue 3, 2009, Pages 220-231

  Banerjee, S ^a   Oneda, B ^b   Yap, L M ^c   Jewell, D P ^d   Matters, G L ^a   Fitzpatrick, L R ^a   Seibold, F ^b   Sterchi, E E ^b   Ahmad, T ^e   Lottaz, D ^b,f   Bond, J S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

^c Department of Gastroenterology ^*  (Australia)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^f UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; MEPRIN; MEPRIN ALPHA; MESSENGER RNA; PROTEIN MEP1A; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENTERITIS; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

EID: 65449141343     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2009.3     Document Type: Article

References (48)

1. Xavier, R.J. & Podolsky, D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007).
2. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
3. Duerr R.H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
4. Hampe, J. et al. Linkage of inflammatory bowel disease to human chromosome 6p. Am. J. Hum. Genet. 65, 1647-1655 (1999).
5. Jiang, W. et al. Fine mapping of MEP1A, the gene encoding the alpha subunit of the metalloendopeptidase meprin, to human chromosome 6P21. Biochem. Biophys. Res. Commun. 216, 630-635 (1995).
6. Bankus, J.M. & Bond, J.S. Expression and distribution of meprin protease subunits in mouse intestine. Arch. Biochem. Biophys. 331, 87-94 (1996).
7. Lottaz, D., Hahn, D., Muller, S., Muller, C. & Sterchi, E.E. Secretion of human meprin from intestinal epithelial cells depends on differential expression of the alpha and beta subunits. Eur. J. Biochem. 259 496-504 (1999).
8. Lottaz, D., Maurer, C.A., Hahn, D., Buchler, M.W. & Sterchi, E.E. Nonpolarized secretion of human meprin alpha in colorectal cancer generates an increased proteolytic potential in the stroma. Cancer Res. 59, 1127-1133 (1999).
9. Lottaz, D. et al. Compartmentalised expression of meprin in small intestinal mucosa: Enhanced expression in lamina propria in coeliac disease. Biol. Chem. 388, 337-341 (2007).
10. Crisman, J.M., Zhang, B., Norman, L.P. & Bond, J.S. Deletion of the mouse meprin beta metalloprotease gene diminishes the ability of leukocytes to disseminate through extracellular matrix. J. Immunol. 172, 4510-4519 (2004).
11. Stocker, W. et al. The metzincins - topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci. 4, 823-840 (1995).
12. Bond, J.S., Matters, G.L., Banerjee, S. & Dusheck, R.E. Meprin metalloprotease expression and regulation in kidney, intestine, urinary tract infections and cancer. FEBS Lett. 579, 3317-3322 (2005).
13. Kruse, M. N. et al. Human meprin alpha and beta homo-oligomers: cleavage of basement membrane proteins and sensitivity to metalloprotease inhibitors. Biochem. J. 378, 383-389 (2004).
14. Hirano, M. et al. Mannan-binding protein blocks the activation of metalloproteases meprin alpha and beta. J. Immunol. 175, 3177-3185 (2005).
15. Bond, J.S., Rojas, K., Overhauser, J., Zoghbi, H.Y. & Jiang, W. The structural genes, MEP1A and MEP1B, for the alpha and beta subunits of the metalloendopeptidase meprin map to human chromosomes 6p and 18q, respectively. Genomics 25, 300-303 (1995).
16. Jiang, W. & Beatty, B.G. Assignment of Mep 1a to mouse chromosome band 17C1-D1 by in situ hybridization. Cytogenet. Cell Genet. 76, 206-207 (1997).
17. Gorbea, C.M. et al. Cloning, expression, and chromosomal localization of the mouse meprin beta subunit. J. Biol. Chem. 268, 21035-21043 (1993).
18. Hahn, D., Illisson, R., Metspalu, A. & Sterchi, E.E. Human N benzoyl-L-tyrosyl- p -aminobenzoic acid hydrolase (human meprin): Genomic structure of the alpha and beta subunits. Biochem. J. 346 (Part 1), 83-91 (2000).
19. Bertenshaw, G.P. et al. Marked differences between metalloproteases meprin A and B in substrate and peptide bond specificity. J. Biol. Chem. 276, 13248-13255 (2001).
20. Jiang, W. & Beatty, B.G. Identification and localization of MEP1A-like sequences (MEP1AL1-4) in the human genome. Biochem. Biophys. Res. Commun. 261, 163-168 (1999).
21. Norman, L.P., Jiang, W., Han, X., Saunders, T.L. & Bond, J.S. Targeted disruption of the meprin beta gene in mice leads to underrepresentation of knockout mice and changes in renal gene expression profiles. Mol. Cell. Biol. 23, 1221-1230 (2003).
22. Norman, L.P., Matters, G.L., Crisman, J.M. & Bond, J.S. Expression of meprins in health and disease. Curr. Top. Dev. Biol. 54, 145-166 (2003).
23. Boismenu, R. & Chen, Y. Insights from mouse models of colitis. J. Leukoc. Biol. 67, 267-278 (2000).
24. Cooper, H.S., Murthy, S.N., Shah, R.S. & Sedergran, D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab. Invest. 69, 238-249 (1993).
25. Dieleman, L.A. et al. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107, 1643-1652 (1994).
26. Egger, B. et al. Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency. Digestion 62, 240-248 (2000).
27. Ni, J., Chen, S. F. & Hollander, D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut 39, 234-241 (1996).
28. Williams, K. L. et al. Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology 120, 925-937 (2001).
29. Barrett, J.C. et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008).
30. Frazer, K.A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861 (2007).
31. Fisher, S.A. et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat. Genet. 40, 710-712 (2008).
32. Franke, A. et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat. Genet. 40, 1319-1323 (2008).
33. Weiss, I.M. & Liebhaber, S.A. Erythroid cell-specific determinants of alpha-globin mRNA stability. Mol. Cell. Biol. 14, 8123-8132 (1994).
34. Lawrance, I.C., Fiocchi, C. & Chakravarti, S. Ulcerative colitis and Crohn's disease: Distinctive gene expression profiles and novel susceptibility candidate genes. Hum. Mol. Genet. 10, 445-456 (2001).
35. Mahler, M. et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am. J. Physiol. 274, G544-G551 (1998).
36. Beynon, R.J. & Bond, J.S. Deficiency of a kidney metalloproteinase activity in inbred mouse strains. Science 219, 1351-1353 (1983).
37. Atreya, R. & Neurath, M.F. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin. Rev. Allergy Immunol. 28, 187-196 (2005).
38. Pang, Y.H., Zheng, C.Q., Yang, X.Z. & Zhang, W.J. Increased expression and activation of IL-12-induced Stat4 signaling in the mucosa of ulcerative colitis patients. Cell. Immunol. 248, 115-120 (2007).
39. Banerjee, S. & Bond, J.S. Prointerleukin-18 is activated by meprin beta in vitro and in vivo in intestinal inflammation. J. Biol. Chem. 283, 31371-31377 (2008).
40. Banks, C., Bateman, A., Payne, R., Johnson, P. & Sheron, N. Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease. J. Pathol. 199, 28-35 (2003).
41. Pender, S.L. et al. Systemic administration of the chemokine macrophage inflammatory protein 1alpha exacerbates inflammatory bowel disease in a mouse model. Gut 54, 1114-1120 (2005).
42. Herzog, C., Kaushal, G.P. & Haun, R.S. Generation of biologically active interleukin-1beta by meprin B. Cytokine 31, 394-403 (2005).
43. von Lampe, B., Barthel, B., Coupland, S.E., Riecken, E.O. & Rosewicz, S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47, 63-73 (2000).
44. Kobayashi, K. et al. Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium. J. Pathol. 209, 376-383 (2006).
45. Garg, P. et al. Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: Contrasting role of gelatinases in the pathogenesis of colitis. J. Immunol. 177, 4103-4112 (2006).
46. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W. & Roder, J.C. Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90, 8424-8428 (1993).
47. Bertenshaw, G.P., Villa, J.P., Hengst, J.A. & Bond, J.S. Probing the active sites and mechanisms of rat metalloproteases meprin A and B. Biol. Chem. 383, 1175-1183 (2002).
48. Medina, C. et al. Increased activity and expression of matrix metalloproteinase-9 in a rat model of distal colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G116-G122 (2003).